{
}
UBS has maintained its "Buy" rating for Novo Nordisk, setting a target price of 750 Danish crowns, influenced by current trends in weight loss drugs, particularly GLP-1. Analyst Jo Walton noted growth for Eli Lilly's Zepbound, while other competitors are seeing declines.
Danske Bank A/S, Denmark's leading bank, operates in four main areas: retail banking, market and investment banking, insurance through Danica Pension, and asset management. By the end of 2024, the bank is expected to manage DKK 1,173.8 billion in current deposits and DKK 1,074.8 billion in current loans, reflecting a delayed recovery in its EPS forecasts.
Goldman Sachs has initiated coverage on Royal Unibrew with a Buy rating and a price target of DKK 630, reflecting an 18% upside. The firm projects a robust EBIT CAGR of 10.4% from FY25 to FY27, anticipating a recovery in EBIT margins to 15.5% by 2027 as the company enhances efficiencies post-acquisitions. This outlook is more optimistic than the Visible Alpha Consensus Data, with estimates for EBIT and EPS 2% to 6% higher.
Danske Bank A/S has initiated a share buy-back programme totaling DKK 5 billion, aiming to repurchase up to 45 million shares from 10 February 2025 to 30 January 2026. In week 12, the bank acquired 207,100 shares, bringing the total to 332,100 shares, representing 0.039% of its share capital.
UBS has maintained its "Buy" rating for Novo Nordisk, setting a target price of 750 Danish crowns. Analyst Jo Walton noted disappointing growth in the US for the GLP-1 weight loss drug Wegovy in the first quarter, indicating that promotional efforts may not have been effective and that the company has lost market share among new patients.
Danske Bank has announced an increase in its dividend to DKK14.70, set to be paid on March 25, yielding 7.7%. Despite a history of dividend instability, the bank maintains a payout ratio of 60% and has shown strong earnings growth, though analysts forecast a slight decline in earnings per share over the next three years. Overall, while the dividend is being raised, concerns about its sustainability remain, suggesting investors may want to consider other income opportunities.
Danske Bank A/S, Denmark's leading bank, operates in retail banking, market and investment banking, insurance, and asset management. By the end of 2024, it managed DKK 1,173.8 billion in current deposits and DKK 1,074.8 billion in current loans. The bank anticipates the Bank of England will cut rates in May, maintaining a 'gradual' approach.
Morgan Stanley has upgraded Zealand Pharma to Overweight, citing the long-term potential of its obesity treatment, petrelintide, following a partnership with Roche. Despite current market challenges, analysts believe the obesity market opportunity remains robust, with petrelintide positioned as a leading therapeutic. The recent decline in Zealand's stock price is seen as an attractive entry point for investors, with potential upside from upcoming data and the partnership's implications for future sales.
Barclays has downgraded Rockwool's stock rating from Overweight to Equalweight while maintaining its price target at DKK3,300. The decision follows a significant rise in the company's share price since early 2024, which has limited potential upside. Despite the downgrade, Barclays' financial performance expectations for Rockwool remain unchanged, indicating the stock is now expected to perform in line with market averages.
Danske Bank A/S has announced an extraordinary dividend of DKK 5.35 per share, in addition to an ordinary dividend of DKK 9.35 per share, following its Annual General Meeting on March 20, 2025. The ex-dividend date is set for March 21, 2025. NASDAQ Derivatives Markets will adjust options and futures accordingly.
Danish Krone
Currency
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
ubs maintains buy rating for novo nordisk with target price of 750 crowns
16:06 28.03.2025
Danske Bank faces delayed recovery as EPS forecasts are adjusted
14:17 28.03.2025
Goldman Sachs initiates buy rating for Royal Unibrew with DKK 630 target
08:51 27.03.2025
danske bank completes week 12 of share buyback program with significant transactions
10:00 24.03.2025
ubs maintains buy rating for novo nordisk despite disappointing wegovy growth
18:16 21.03.2025
Danske Bank raises dividend to DKK14.70 amid stable earnings outlook
13:59 21.03.2025
danske bank anticipates bank of england rate cuts in may
12:09 21.03.2025
Morgan Stanley upgrades Zealand Pharma citing long-term obesity market potential
Euro
Danish Krone
United States Dollar
Zealand Pharma A/S
Hoffmann-La Roche AG
Novo Nordisk A/S
DNK
USA
Show more
09:56 21.03.2025
Barclays downgrades Rockwool stock rating to equalweight while maintaining price target
09:06 21.03.2025
Danske Bank announces extraordinary dividend alongside regular payout for shareholders
17:48 20.03.2025
Trending
Subcategory
Corporate News
Stock Market Updates
Industry Trends
Banking Regulations
Retail and Consumer Goods
Finance Mergers & Acquisitions
Global Financial Events
CEO Changes
Industry Mergers & Acquisitions
Startups & Entrepreneurship
Financial Scams and Security
Market Analysis and Predictions
Supply Chain Management
Global Trade Developments
Central Bank Actions
Government Economic Policies
Workplace Trends
Government Policies
Energy Sector Developments
European Securities and Markets Authority
Countries:
Companies:
Tesla, Inc.
JPMorgan Chase & Co.
Barclays PLC
The Goldman Sachs Group, Inc.
Deutsche Bank Money Market PP
Bank of America Corporation
Morgan Stanley
Wells Fargo & Company
Citigroup Inc.
Credit Suisse Strategic Income I
Commerzbank AG
UBS Group AG
UniCredit S.p.A.
Apple Inc.
Amazon.com, Inc.
NVIDIA Corporation
Lloyds Banking Group plc
BNP Paribas SA
Basler Kantonalbank
Google Inc.
Currencies:
United States Dollar
Euro
Swiss Franc
British Pound Sterling
Chinese Yuan
Indian Rupee
Japanese Yen
United Arab Emirates Dirham
Canadian Dollar
Swedish Krona
Australian Dollar
Mexican Peso
Hong Kong Dollar
Brazilian Real
Danish Krone
Offshore Chinese Yuan
Singapore Dollar
Thai Baht
Indonesian Rupiah
Kuwaiti Dinar
People: